Dosing with ropinirole in a clinical setting

Acta Neurologica Scandinavica

Volumn 106, Issue 4, 2002, Pages 200-204

  Korczyn, A D ^a   Thalamas, C ^a   Adler, C H ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Dopamine agonist; Dosing; Parkinson's disease; Ropinirole; Therapeutics

Indexed keywords

BROMOCRIPTINE; LEVODOPA; ROPINIROLE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; PARKINSON DISEASE; PHASE 3 CLINICAL TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CLINICAL TRIALS, PHASE III; DATA COLLECTION; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 0036786729     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2002.01343.x     Document Type: Article

References (6)

1. ADLER CH, SETHI KD, HAUSER RA et al. Ropinirole for the treatment of early Parkinson's disease. Neurology 1997;49:393-9.
2. KORCZYN AD, BRUNT ER, LARSEN JP, NAGY Z, POEWE WH, RUGGIERI S. A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. Neurology, 1999;53:364-70. with erratum Neurology 1999;53:1162.
3. RASCOL O, BROOKS DJ, KORCZYN AD, DE DEYN PP, CLARKE CE, LANG AE, ON BEHALF OF THE 056 STUDY GROUP. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J M ed 2000;342:1484-91.
4. RASCOL O, BROOKS DJ, BRUNT ER, KORCZYN AD, POEWE WH, STOCCHI F, ON BEHALF OF THE 056 STUDY GROUP. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year L-dopa-controlled study. Mov Disord 1998;13:39-45.
5. KORCZYN AD, BROOKS DJ, BRUNT ER, POEWE WH, RASCOL O, STOCCHI F, ON BEHALF OF THE 053 STUDY GROUP. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. Mov Disord 1998;13:46-51.
6. FAHN S, ELTON RL, MEMBERS OF THE UPDRS DEVELOPMENT COMMITTEE. Unified Parkinson's Disease Rating Scale. In: FAHN S, MARSDEN CD, CALNE DB, GOLDSTEIN M, eds. Recent developments in Parkinson's disease, Vol. 2. Florham Park, NJ: MacMillan Healthcare Information, 1987:153-63.